New Delhi, Sept 19: Scientists examined the effectiveness of common household fabrics used in homemade masks in blocking droplets generated by coughing and sneezing, and have found that they are considerably protective even as a single layer.
Search
Health & Food
London, Sept 18: Researchers have created a 90-minute high speed COVID-19 test which does not require a laboratory and can be performed in cartridges smaller than a mobile phone with high accuracy.
Ludhiana, Sept 18: DMCH Cancer Care Centre in collaboration with American Oncology Institute recently started a new diagnostic service (PSMA-PET Scan) in treating various prostate cancer.
Vaccine candidates for COVID-19 should elicit a broad immune response that includes antibodies, and the body's helper and killer T cells, according to a study which says weak or uncoordinated immunity may lead to a poor disease outcome.
New Delhi, Sept 17: Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year. The remarks come at a time when India is recording more than 50 lakh cases and people are awaiting the vaccine with bated breath.
Beirut, Sept 15: Once herd immunity is attained, the novel coronavirus may follow suit and become a seasonal virus in countries with temperate climates, but until that time, COVID-19 will continue to spread across the seasons, a new study says.
New Delhi, Sept 13: A group of scientists in India is working on genomic sequences of SARS-CoV-2 around the World, including India, to identify genetic variability and potential molecular targets in virus and human to find the best possible answer to combat the COVID-19 virus.
Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model.
New Delhi, Sept 12: Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries. In an order, a copy of which has been accessed by PTI, DCGI Dr V G Somani on Friday also directed...
New Delhi, Sept 10: The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India.